Carbapenemase detection in Acinetobacter baumannii clones resistant to imipenem

被引:6
作者
Gallego, L
Canduela, MJ
Sevillano, E
Pujana, I
Calvo, F
Umaran, A
Martín, G
机构
[1] Univ Basque Country, Dept Microbiol Immunol & Parasitol, Fac Med & Odontol, E-48080 Bilbao, Vizcaya, Spain
[2] Hosp Santa Marina, Microbiol Serv, Vizcaya, Spain
[3] Hosp San Eloy, Microbiol Serv, Vizcaya, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2004年 / 22卷 / 05期
关键词
A; baumannii; imipenem; PCR; carbapenemase; metallo-beta-lactamase;
D O I
10.1157/13059818
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
INTRODUCTION. The aim of this study was to detect carbapenemases in imipenem-resistant Acinetobacter baumannii isolates obtained in the microbiology department of a Basque Country Public Health Service hospital over a period of 19 months, and to genetically characterize the resistant clones. METHODS. Susceptibility tests to imipenem, meropenem, ticarcillin, ceftazidime, cefotaxime, cefepime and aztreonam were done by determining the minimum inhibitory concentration on agar plates. A tRNA technique was used for species identification and PCR with primers ERIC2, AP3 and M13 for genetic typing of resistant isolates. Carbapenemase production was detected by the Hodge test and metallo-beta-lactamase by the EDTA test and Etest MBL. RESULTS. A total of 76 isolates were resistant to imipenem and 49 of these were resistant to all the betalactam antibiotics tested. Genetic typing showed three predominant clones, denominated 1 (9 isolates), 11 (48 isolates) and Ill (8 isolates). Hodge and EDTA tests were positive in 45 and 8 isolates belonging to clone 11, 8 and 4 belonging to clone 1 and 7 and 3 belonging to clone Ill, respectively. The Etest confirmed 7 results (45% of the 17 positive EDTA test isolates). CONCLUSION. Our results show that one factor contributing to the high level of imipenem resistance in the isolates analyzed is dissemination of a predominant, multiresistant clone able to produce OXA-type carbapenemases and metallo-beta-lactamases.
引用
收藏
页码:262 / 266
页数:5
相关论文
共 20 条
[1]   Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii [J].
Afzal-Shah, M ;
Woodford, N ;
Livermore, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :583-588
[2]   OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain [J].
Bou, G ;
Oliver, A ;
Martínez-Beltran, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1556-1561
[3]   PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii [J].
Bou, G ;
Cerveró, G ;
Domínguez, MA ;
Quereda, C ;
Martínez-Beltrán, J .
CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (12) :635-643
[4]   Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme:: High-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases [J].
Bou, G ;
Cerveró, G ;
Domínguez, MA ;
Quereda, C ;
Martínez-Beltrán, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) :3299-3305
[5]   Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii [J].
Corbella, X ;
Montero, A ;
Pujol, M ;
Domínguez, MA ;
Ayats, J ;
Argerich, MJ ;
Garrigosa, F ;
Ariza, J ;
Gudiol, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (11) :4086-4095
[6]   Appearance of IMP-1 metallo-β-lactamase in Europe [J].
Cornaglia, G ;
Riccio, ML ;
Mazzariol, A ;
Lauretti, L ;
Fontana, R ;
Rossolini, GM .
LANCET, 1999, 353 (9156) :899-900
[7]  
Da Silva GJ, 2002, FEMS MICROBIOL LETT, V215, P33, DOI 10.1111/j.1574-6968.2002.tb11366.x
[8]   Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92 [J].
Donald, HM ;
Scaife, W ;
Amyes, SGB ;
Young, HK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) :196-199
[9]   Acinetobacter species identification by using tRNA spacer fingerprinting [J].
Ehrenstein, B ;
Bernards, AT ;
Dijkshoorn, L ;
GernerSmidt, P ;
Towner, KJ ;
Bouvet, PJM ;
Daschner, FD ;
Grundmann, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (10) :2414-2420
[10]  
FERNANDEZCUENCA F, 2002, ENFERM INFECC MIC S1, V20, P122